Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in dementia
and eventual death. It is the leading cause of dementia and the number of cases are …

Abstract Introduction The number of Alzheimer's Disease (AD) patients is increasing with
increased life expectancy and 115.4 million people are expected to be affected in 2050 …

Background Patients with Alzheimer's disease (AD) are known to exhibit visuospatial
processing impairment, as reflected in eye movements from the early stages of the disease …

Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

There has been increasing interest in non-invasive predictors of Alzheimer's disease (AD)
as an initial screen for this condition. Previously, successful attempts leveraged eye-tracking …

Extensive research has demonstrated that eye-tracking tasks can effectively indicate
cognitive impairment. For example, lab-based eye-tracking tasks, such as the antisaccade …

An opportune early diagnosis of Alzheimer's disease (AD) would help to overcome
symptoms and improve the quality of life for AD patients. Research studies have identified …

Patients with Alzheimer's disease (AD) typically present with attentional and oculomotor
abnormalities that can have an impact on visual processing and associated cognitive …

Patients with Alzheimer's disease (AD) develop progressive language, visuoperceptual,
attentional, and oculomotor changes that can have an impact on their reading …

A long tradition in eye movement research has focused on three linguistic variables
explaining fixation durations during sentence reading: word length, frequency, and …